Skip to main content
Menu
US

LH-RH, [125I]-[D-Trp6]-, 10µCi

Luteinizing Hormone Releasing Hormone (LHRH), labeled with 125I. LHRH binds LHRH receptors, and is a drug target for cancer therapy.

For research use only. Not for use in diagnostic procedures.

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Feature Specification
Fresh Lot Days Second Monday of each month
Label Position Nominally Labeled
Molecular Weight ~1436.5
Receptor Gonadotropin-releasing hormone

Luteinizing Hormone Releasing Hormone (LHRH), labeled with 125I. LHRH binds LHRH receptors, and is a drug target for cancer therapy.

For research use only. Not for use in diagnostic procedures.

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Product Variants
Unit Size: 10 µCi
Part #:
NEX365010UC
List Price
USD 1,894.00
Unit Size: 50 µCi
Part #:
NEX365050UC
List Price
USD 6,924.00

Overview

10 µCiQuantities of LH-RH, [125I]-[D-Trp6]- are available for your research.

We offer radioligands and radiolabeled biomolecules to use as tracers, for radioimmunoassays (RIAs), for autoradiographic visualization, or for performing saturation and competition radioligand binding assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radiolabeled compounds is fully characterized for pharmacological action and validated in binding assays.

Radiochemicals remain the most sensitive method for probing binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.

References for NEX365:

  1. Mehmanesh, H., Almeida, O.F., Nikolarakis, K.E., Herz, A. (1988), Hypothalamic LH-RH release after acute and chronic treatment with morphine studied in a combined in vivo/in vitro model. Brain Res, 451 (1-2): 69-76.
  2. Carelli, C., Ralamboranto, L., Audibert, F., Gaillard, J., Briquelet, N., Dray, F., Fafeur, V., Haour, F., Chedid, L. (1985), Immunological castration by a totally synthetic vaccine: modification of biological properties of LH-RH after conjugation to adjuvant-active muramyl peptide. Int J Immunopharmacol, 7 (2): 215-224.

Specifications

Molecular Weight
~1436.5
Specific Activity
2200.0 Ci/mmol
Application
Drug Discovery & Development
Brand
NEN Radiochemicals
Buffer/Solvent
Lyophilized
Detection Modality
Radiometric
Fresh Lot Days
Second Monday of each month
Label Position
Nominally Labeled
Packaging
NENSure vial
Radioisotope
125I
Receptor
Gonadotropin-releasing hormone
Shipping Conditions
Shipped Ambient
Special Ordering Information
This is a radioactive product - shipping address must have a license to receive radioactive materials.
Storage Conditions
4°C
Therapeutic Area
Cancer
Unit Size
10 µCi

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Product Info Icon
Product Info
Calendar: NEN® Radiochemicals 2024 Fresh Lot
Flyer Icon
Flyer
NENSure: The safest packaging for radiochemicals
Scroll Icon